83 related articles for article (PubMed ID: 25130308)
21. Hospital academic status and value of care for nonmetastatic colon cancer.
Veenstra CM; Epstein AJ; Liao K; Griggs JJ; Pollack CE; Armstrong K
J Oncol Pract; 2015 May; 11(3):e304-12. PubMed ID: 25901052
[TBL] [Abstract][Full Text] [Related]
22. Commentary: The sublobar resections and the difference between a conjecture and a theorem.
Bertolaccini L; Spaggiari L
J Thorac Cardiovasc Surg; 2023 Mar; 165(3):862-863. PubMed ID: 35760615
[No Abstract] [Full Text] [Related]
23. Effect of Clinical Trial Participation on Costs to Payers in Metastatic Non-Small-Cell Lung Cancer.
Merkhofer C; Chennupati S; Sun Q; Eaton KD; Martins RG; Ramsey SD; Goulart BHL
JCO Oncol Pract; 2021 Aug; 17(8):e1225-e1234. PubMed ID: 34375561
[TBL] [Abstract][Full Text] [Related]
24. "Factors associated with non-small cell lung cancer treatment costs in a Brazilian public hospital".
de Barros Reis C; Knust RE; de Aguiar Pereira CC; Portela MC
BMC Health Serv Res; 2018 Feb; 18(1):124. PubMed ID: 29454338
[TBL] [Abstract][Full Text] [Related]
25. Impact of the collaborative care model on medical spending.
Wolk CB; Wilkinson E; Livesey C; Oslin DW; Connolly KR; Smith-McLallen A; Press MJ
Am J Manag Care; 2023 Oct; 29(10):499-502. PubMed ID: 37870543
[TBL] [Abstract][Full Text] [Related]
26. Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer Study Group 821?
Altorki NK; Chow OS
J Thorac Cardiovasc Surg; 2024 Jan; 167(1):367-370. PubMed ID: 37597739
[No Abstract] [Full Text] [Related]
27. Enhancing surgical precision in early-stage non-small cell lung cancer: A novel approach through temporary pulmonary vascular occlusion.
Zhao Y; You B; Li H
Thorac Cancer; 2024 Jun; ():. PubMed ID: 38837623
[TBL] [Abstract][Full Text] [Related]
28. Statistical modeling of longitudinal medical cost trajectory: renal cell cancer care cost analyses.
Wang S; Shen Y; Shih YT; Xu Y; Li L
Biostatistics; 2020 Jul; ():. PubMed ID: 34269395
[TBL] [Abstract][Full Text] [Related]
29. Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller.
Ochiai S; Yamakado K; Kodama H; Nomoto Y; Ii N; Takaki H; Sakuma H
Int J Clin Oncol; 2015 Jun; 20(3):499-507. PubMed ID: 25130494
[TBL] [Abstract][Full Text] [Related]
30. Survival Rates after Thermal Ablation versus Stereotactic Radiation Therapy for Stage 1 Non-Small Cell Lung Cancer: A National Cancer Database Study.
Uhlig J; Ludwig JM; Goldberg SB; Chiang A; Blasberg JD; Kim HS
Radiology; 2018 Dec; 289(3):862-870. PubMed ID: 30226453
[TBL] [Abstract][Full Text] [Related]
31. Survival outcomes for surgical resection versus CT-guided percutaneous ablation for stage I non-small cell lung cancer (NSCLC): a systematic review and meta-analysis.
Chan MV; Huo YR; Cao C; Ridley L
Eur Radiol; 2021 Jul; 31(7):5421-5433. PubMed ID: 33449192
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease.
Tselikas L; Garzelli L; Mercier O; Auperin A; Lamrani L; Deschamps F; Yevich S; Roux C; Mussot S; Delpla A; Varin F; Hakime A; Teriitehau C; Le Péchoux C; Pradère P; Caramella C; Besse B; Fadel E; de Baere T
Diagn Interv Imaging; 2021 Jan; 102(1):19-26. PubMed ID: 33020025
[TBL] [Abstract][Full Text] [Related]
33. Survival Outcomes of Treatment with Radiofrequency Ablation, Stereotactic Body Radiotherapy, or Sublobar Resection for Patients with Clinical Stage I Non-Small-Cell Lung Cancer: A Single-Center Evaluation.
Iguchi T; Hiraki T; Matsui Y; Mitsuhashi T; Katayama N; Katsui K; Soh J; Sakurai J; Gobara H; Toyooka S; Kanazawa S
J Vasc Interv Radiol; 2020 Jul; 31(7):1044-1051. PubMed ID: 32471699
[TBL] [Abstract][Full Text] [Related]
34. Sublobar resection compared with stereotactic body radiation therapy and ablation for early stage non-small cell lung cancer: A National Cancer Database study.
Wu J; Bai HX; Chan L; Su C; Zhang PJ; Yang L; Zhang Z
J Thorac Cardiovasc Surg; 2020 Nov; 160(5):1350-1357.e11. PubMed ID: 32033815
[TBL] [Abstract][Full Text] [Related]
35. Sublobar Resection, Radiofrequency Ablation or Radiotherapy in Stage I Non-Small Cell Lung Cancer.
Safi S; Rauch G; op den Winkel J; Kunz J; Schneider T; Bischof M; Heussel CP; Huber PE; Herth FJ; Dienemann H; Hoffmann H
Respiration; 2015; 89(6):550-7. PubMed ID: 25968471
[TBL] [Abstract][Full Text] [Related]
36. Pre-operative lung ablation prediction using deep learning.
Keshavamurthy KN; Eickhoff C; Ziv E
Eur Radiol; 2024 May; ():. PubMed ID: 38775950
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation for stage Zhao Q; Wang J; Fu YL; Hu B
Thorac Cancer; 2023 Nov; 14(32):3181-3190. PubMed ID: 37740563
[TBL] [Abstract][Full Text] [Related]
38. Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?
Palussière J; Cazayus M; Cousin S; Cabart M; Chomy F; Catena V; Buy X
Curr Oncol Rep; 2021 May; 23(7):81. PubMed ID: 33948744
[TBL] [Abstract][Full Text] [Related]
39. Lung Ablation: Indications and Techniques.
Tafti BA; Genshaft S; Suh R; Abtin F
Semin Intervent Radiol; 2019 Aug; 36(3):163-175. PubMed ID: 31435124
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
